O'Connor Anthony, Gill Sarah, Neary Elaine, White Sarah, Ford Alexander C
Department of Gastroenterology, Trinity College Dublin, Tallaght University Hospital, Dublin, Ireland.
Department of Clinical Nutrition, Trinity College Dublin, Tallaght University Hospital, Dublin, Ireland.
Aliment Pharmacol Ther. 2025 Jan;61(1):177-185. doi: 10.1111/apt.18337. Epub 2024 Oct 11.
Anxiety and depression are associated strongly with irritable bowel syndrome (IBS). Dietary therapies are used increasingly in the management of IBS, but the impact of common mental disorders on response to these has not been well studied.
To examine whether symptoms compatible with common mental disorders influence response to dietary interventions.
Prospective cohort study of adults, with either diarrhoea-predominant or mixed bowel habits, IBS Severity Scoring System [IBS-SSS] score ≥ 75 points. Participants completed the Hospital Anxiety and Depression score (HADS) and attended initially for British Dietary Association advice for IBS. IBS-SSS was re-checked 3 months later to assess response. If primary endpoint (≥ 50 point decrease in IBS-SSS) was not achieved, patients were offered low fermentable oligo-, di- and monosaccharides and polyol diet and repeated IBS-SSS after another 3 months. Secondary endpoints included of change in IBS-SSS and effect of symptom severity on response.
In total, 448 patients took part, average age of 42 years and 79.0% were female. 69.9% of participants had HADS-A scores ≥ 8 and 39.3% with HADS-D scores ≥ 8. Average IBS-SSS score at baseline was 290 (SD 86). No significant difference was noted in achievement of the primary endpoint according to HADS-A scores (53.4% vs. 62.2% by ITT in those with HADS-A ≥ 8 vs. HADS-A < 8, p = 0.09). Patients with HADS-D ≥ 8 were significantly less likely to achieve the primary endpoint compared with those with HADS-D < 8 (43.8% vs. 64.0% by ITT, p < 0.01).
Understanding psychological profile of patients can help predicting their response to IBS dietary interventions.
焦虑和抑郁与肠易激综合征(IBS)密切相关。饮食疗法在IBS的管理中应用越来越广泛,但常见精神障碍对这些疗法反应的影响尚未得到充分研究。
研究与常见精神障碍相符的症状是否会影响对饮食干预的反应。
对以腹泻为主或排便习惯混合、IBS严重程度评分系统(IBS-SSS)得分≥75分的成年人进行前瞻性队列研究。参与者完成医院焦虑抑郁量表(HADS)评分,并最初接受英国饮食协会针对IBS的建议。3个月后重新检查IBS-SSS以评估反应。如果未达到主要终点(IBS-SSS降低≥50分),则为患者提供低可发酵寡糖、双糖、单糖和多元醇饮食,并在再过3个月后重复进行IBS-SSS评估。次要终点包括IBS-SSS的变化以及症状严重程度对反应的影响。
共有448名患者参与,平均年龄42岁,79.0%为女性。69.9%的参与者HADS-A评分≥8,39.3%的参与者HADS-D评分≥8。基线时IBS-SSS平均评分为290(标准差86)。根据HADS-A评分,在达到主要终点方面未观察到显著差异(HADS-A≥8者意向性分析ITT为53.4%,HADS-A<8者为62.2%,p=0.09)。与HADS-D<8的患者相比,HADS-D≥8的患者达到主要终点的可能性显著降低(ITT分别为43.8%和64.0%,p<0.01)。
了解患者的心理状况有助于预测他们对IBS饮食干预的反应。